{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:10:50Z","timestamp":1760616650296,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.rmed.2019.07.002","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T14:40:40Z","timestamp":1562078440000},"page":"58-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Safety of tiotropium Respimat\u00ae in black or African-American patients with symptomatic asthma"],"prefix":"10.1016","volume":"155","author":[{"given":"LeRoy M.","family":"Graham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huib A.M.","family":"Kerstjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Vogelberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eckard","family":"Hamelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley J.","family":"Szefler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendelgard","family":"Pisternick-Ruf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Engel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"El Azzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Unseld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Foggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2018","series-title":"GINA Report: Global Strategy for Asthma Management and Prevention","author":"Global Initiative for Asthma","key":"10.1016\/j.rmed.2019.07.002_bib1"},{"key":"10.1016\/j.rmed.2019.07.002_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jaci.2008.04.024","article-title":"Improved overall trends but persistent racial disparities in emergency department visits for acute asthma, 1993-2005","volume":"122","author":"Ginde","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.07.002_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40265-018-0862-1","article-title":"Efficacy and safety of tiotropium in children and adolescents","volume":"78","author":"Hamelmann","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.rmed.2019.07.002_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1183\/16000617.0052-2015","article-title":"Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?","volume":"25","author":"Busse","year":"2016","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2019.07.002_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaip.2015.08.017","article-title":"The effect of tiotropium in symptomatic asthma despite low- to medium-dose inhaled corticosteroids: a randomized controlled trial","volume":"4","author":"Paggiaro","year":"2016","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2019.07.002_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124109","article-title":"Long-term once-daily tiotropium Respimat\u00ae is well tolerated and maintains efficacy over 52 weeks in patients with symptomatic asthma in Japan: a randomised, placebo-controlled study","volume":"10","author":"Ohta","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.rmed.2019.07.002_bib7","first-page":"414","article-title":"Tiotropium add-on therapy has a safety profile comparable with that of placebo in children and adolescents with symptomatic asthma","volume":"72","author":"Vogelberg","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2019.07.002_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.rmed.2016.07.001","article-title":"Safety and tolerability of once-daily tiotropium Respimat(\u00ae) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: a pooled safety analysis","volume":"118","author":"Dahl","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2019.07.002_bib9","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1001\/jama.2015.13277","article-title":"Anticholinergic vs long-acting beta-agonist in combination with inhaled corticosteroids in black adults with asthma: the BELT randomized clinical trial","volume":"314","author":"Wechsler","year":"2015","journal-title":"J. Am. Med. Assoc."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119302264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119302264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:51:44Z","timestamp":1760615504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611119302264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":9,"alternative-id":["S0954611119302264"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2019.07.002","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of tiotropium Respimat\u00ae in black or African-American patients with symptomatic asthma","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2019.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}